Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.
Aflatoonian MR, Sharifi I, Aflatoonian B, Bamorovat M, Heshmatkhah A, Babaei Z, Ghasemi Nejad Almani P, Mohammadi MA, Salarkia E, Aghaei Afshar A, Sharifi H, Sharifi F, Khosravi A, Khatami M, Arefinia N, Fekri A, Farajzadeh S, Khamesipour A, Mohebali M, Gouya MM, Shirzadi MR, Varma RS. Aflatoonian MR, et al. Among authors: heshmatkhah a. PLoS Negl Trop Dis. 2019 Jun 12;13(6):e0007423. doi: 10.1371/journal.pntd.0007423. eCollection 2019 Jun. PLoS Negl Trop Dis. 2019. PMID: 31188834 Free PMC article.
Geographical distribution and molecular characterization for cutaneous leishmaniasis species by sequencing and phylogenetic analyses of kDNA and ITS1 loci markers in south-eastern Iran.
Ramezany M, Sharifi I, Babaei Z, Ghasemi Nejad Almani P, Heshmatkhah A, Keyhani A, Aflatoonian MR, Mohammadi MA, Sharifi F, Bamorovat M. Ramezany M, et al. Among authors: heshmatkhah a. Pathog Glob Health. 2018 May;112(3):132-141. doi: 10.1080/20477724.2018.1447836. Epub 2018 Mar 14. Pathog Glob Health. 2018. PMID: 29536818 Free PMC article.
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
Oliaee RT, Sharifi I, Afgar A, Kareshk AT, Asadi A, Heshmatkhah A, Bamorovat M, Jafarzadeh A, Mohammadi MA, Daneshvar H. Oliaee RT, et al. Among authors: heshmatkhah a. Trop Med Int Health. 2018 Jun;23(6):622-633. doi: 10.1111/tmi.13062. Epub 2018 May 21. Trop Med Int Health. 2018. PMID: 29709098 Free article.
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
Bamorovat M, Sharifi I, Fekri A, Keyhani A, Aflatoonian MR, Heshmatkhah A, Oliaee RT, Khosravi A, Naderi A, Parizi MH, Mostafavi M, Varma RS. Bamorovat M, et al. Among authors: heshmatkhah a. Microb Pathog. 2019 Mar;128:162-170. doi: 10.1016/j.micpath.2018.12.040. Epub 2018 Dec 21. Microb Pathog. 2019. PMID: 30583021
Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.
Bamorovat M, Sharifi I, Dabiri S, Shamsi Meymandi S, Karamoozian A, Amiri R, Heshmatkhah A, Borhani Zarandi M, Aflatoonian MR, Sharifi F, Kheirandish R, Hassanzadeh S. Bamorovat M, et al. Among authors: heshmatkhah a. PLoS Negl Trop Dis. 2021 Jan 28;15(1):e0009089. doi: 10.1371/journal.pntd.0009089. eCollection 2021 Jan. PLoS Negl Trop Dis. 2021. PMID: 33507940 Free PMC article.
A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor.
Karimi T, Sharifi I, Aflatoonian MR, Aflatoonian B, Mohammadi MA, Salarkia E, Babaei Z, Zarinkar F, Sharifi F, Hatami N, Khosravi A, Eskandari A, Solimani E, Shafiee M, Mozaffari M, Heshmatkhah A, Amiri R, Farajzadeh S, Kyhani A, Aghaei Afshar A, Jafarzadeh A, Bamorovat M. Karimi T, et al. Among authors: heshmatkhah a. Parasit Vectors. 2021 Feb 24;14(1):122. doi: 10.1186/s13071-021-04619-3. Parasit Vectors. 2021. PMID: 33627184 Free PMC article.
Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment.
Bamorovat M, Sharifi I, Aflatoonian MR, Karamoozian A, Tahmouresi A, Jafarzadeh A, Heshmatkhah A, Sharifi F, Salarkia E, Khaleghi T, Khosravi A, Nooshadokht M, Zarandi MB, Barghi M. Bamorovat M, et al. Among authors: heshmatkhah a. Int J Infect Dis. 2022 Sep;122:155-161. doi: 10.1016/j.ijid.2021.09.050. Epub 2021 Sep 24. Int J Infect Dis. 2022. PMID: 34571149 Free PMC article.
15 results